Zifan Yang

Zifan Yang

Auto-generated profile, based on publicly available information

Zifan Yang

Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
QMQian Meng
Qian Meng
XZXiaoyu Zhang
Xiaoyu Zhang
YCYuwen Chen
Yuwen Chen
HYHao Yang
Hao Yang
JLJinshuai Liu
Jinshuai Liu
YWYu Wang
Yu Wang
Drug delivery for epilepsy treatment faces enormous challenges, where the sole focus on enhancing the ability of drugs to penetrate the blood–brain barrier (BBB) through ligand modification is insufficient because of the absence of seizure-specific drug accumulation. In this study, an amphipathic drug carrier with a glucose transporter (GLUT)-targeting capability was synthesised by conjugating 2-deoxy-2-amino-D-glucose (2-DG) to the model carrier DSPE-PEG2k. A 2-DG-modified nano drug delivery system (NDDS) possessing robust stability and favourable biocompatibility was then fabricated using the nanoprecipitation method. The results showed that the 2-DG-modified NDDS exhibited enhanced cellular uptake by brain capillary endothelial cells and neuronal cells. Most importantly, the 2-DG-modified NDDS exhibited enhanced BBB penetration and brain accumulation, especially in the epileptic brain, thus achieving seizure-based on-demand drug delivery. Our study provides a simple and smart strategy for the delivery of anti-seizure medicines.

5 October 2025 in Neuroscience
Verified
Journal Article
Closed access
RLRan Li
Ran Li
KZKehong Zeng
Kehong Zeng
JLJinshuai Liu
Jinshuai Liu
ZYZifan Yang
Zifan Yang
YWYu Wang
Yu Wang